REMERON Side Effects

7020986-9 | Anxiety, Incorrect Dose Administered, Road Traffic Accident, Somnolence
on Sep 21, 2010 Female patient from JAPAN , weighting 136.7 lb, was diagnosed with depression (What is depression?), insomnia and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), incorrect dose administered, road traffic accident, somnolence. Remeron dosage: 15 Mg;qd;po. During the same period patient was treated with ZOLPIDEM TARTRATE (1 Df;qd;po) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CRESTOR (View Crestor Review and Crestor Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

7020752-4 | Compulsive Shopping
Patient was taking Remeron (View Usage). Patient had the following side effects: compulsive shopping on Sep 17, 2010 from BELGIUM Additional patient health information: Male patient , 52 years of age, was diagnosed with sleep disorder (What is sleep disorder?) and. Remeron dosage: .

7020750-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Burning Sensation, Liver Disorder, Oedema Peripheral, Rhabdomyolysis, White Blood Cell Count Decreased
Adverse event was reported on Sep 17, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 15 Mg; Qd; Po) was diagnosed with adjustment disorder, pollakiuria and. Location: JAPAN , 39 years of age, weighting 113.1 lb, After Remeron was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, burning sensation, liver disorder, oedema peripheral, rhabdomyolysis, white blood cell count decreased. During the same period patient was treated with BUP 4 (PROPIVERINE HYDROCHLORIDE /01241602/) (20 Mg; Po) (View Bup-4 (propiverine Hydrochloride /01241602/) Review and Bup-4 (propiverine Hydrochloride /01241602/) Label ), TAKEPRON QD (CON.) (View Takepron Qd (con.) Review and Takepron Qd (con.) Label ), DEPAS (CON.) (View Depas (con.) Review and Depas (con.) Label ), ROHYPNOL (CON.) (View Rohypnol (con.) Review and Rohypnol (con.) Label ), LENDORMIN D (CON.) (View Lendormin D (con.) Review and Lendormin D (con.) Label ), MAGMITT (CON.) (View Magmitt (con.) Review and Magmitt (con.) Label ), GASCON (CON.) (View Gascon (con.) Review and Gascon (con.) Label ), LOXONIN /00890702/ (CON.) (View Loxonin /00890702/ (con.) Review and Loxonin /00890702/ (con.) Label ). Patient was hospitalized.

7008756-9 | Anaemia, Coma Scale, Hypokalaemia, Hypotension, Off Label Use, Suicide Attempt, Tachycardia, Tachypnoea
on Sep 09, 2010 Female patient from SWITZERLAND , 17 years of age, was diagnosed with major depression and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, coma scale, hypokalaemia, hypotension, off label use, suicide attempt, tachycardia, tachypnoea. Remeron dosage: 15 Mg; Qd; Po, 30 Mg; Qd; Po. During the same period patient was treated with SEROQUEL (25 Mg; Tid; Po, 700 Mg; ; Po, 2100 Mg; Once; Po) (View Seroquel Review and Seroquel Label ), NOZINAN /00038603/ (View Nozinan /00038603/ Review and Nozinan /00038603/ Label ), TEMESTA (View Temesta Review and Temesta Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MEFENACID (View Mefenacid Review and Mefenacid Label ). Patient was hospitalized.


7007591-5 | Duodenal Ulcer Perforation, Haemorrhagic Anaemia, Peripheral Ischaemia, Post Procedural Complication, Shock Haemorrhagic, Weight Decreased
on Sep 15, 2010 Female patient from SWITZERLAND , 75 years of age, weighting 94.80 lb, was diagnosed with depression (What is depression?), peripheral vascular disorder, essential hypertension and was treated with Remeron (View Usage). Patient had the following side effects: duodenal ulcer perforation, haemorrhagic anaemia, peripheral ischaemia, post procedural complication, shock haemorrhagic, weight decreased. Remeron dosage: 30 Mg;po. During the same period patient was treated with ASPIRIN (100 Mg;qd;po) (View Aspirin Review and Aspirin Label ), ENALAPRIL MALEATE (10 Mg;qd;po) (View Enalapril Maleate Review and Enalapril Maleate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

7007488-0 | Depression, Impulsive Behaviour, Insomnia, Panic Attack, Skin Laceration, Suicide Attempt
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: depression (What is depression?), impulsive behaviour, insomnia, panic attack, skin laceration, suicide attempt on Sep 10, 2010 from JAPAN Additional patient health information: Female patient , 42 years of age, weighting 143.3 lb, was diagnosed with depression (What is depression?), panic attack and. Remeron dosage: 15 Mg; Bid; Po. During the same period patient was treated with PAXIL (10 Mg; Qd; Po, ; Po) (View Paxil Review and Paxil Label ), LORAZEPAM (1 Mg; Tid; Po) (View Lorazepam Review and Lorazepam Label ), SEPAZON (CLOXAZOLAM) (1 Mg; Tid; Po) (View Sepazon (cloxazolam) Review and Sepazon (cloxazolam) Label ), LEXOTAN (BROMAZEPAM) (2 Mg; Tid; Po) (View Lexotan (bromazepam) Review and Lexotan (bromazepam) Label ), ALLELOCK (View Allelock Review and Allelock Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), HALCION (View Halcion Review and Halcion Label ).

7006390-8 | Anxiety, Apparent Life Threatening Event, Depressed Level Of Consciousness, Impaired Driving Ability, Incorrect Dose Administered, Road Traffic Accident, Somnolence
Adverse event was reported on Sep 03, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg; Qd; Po) was diagnosed with depression (What is depression?), insomnia and. Location: JAPAN , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), apparent life threatening event, depressed level of consciousness, impaired driving ability, incorrect dose administered, road traffic accident, somnolence. During the same period patient was treated with ZOLPIDEM TARTRATE (1 Df; Qd; Po) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CRESTOR (View Crestor Review and Crestor Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

6980335-9 | Asphyxia, Completed Suicide, Dizziness, Dysgeusia, Musculoskeletal Stiffness, Restlessness, Thirst
on Sep 03, 2010 Male patient from JAPAN , 73 years of age, weighting 108.0 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: asphyxia, completed suicide, dizziness (What is dizziness?), dysgeusia, musculoskeletal stiffness, restlessness, thirst. Remeron dosage: 15 Mg; Qd; Po, 30 Mg; Qd; Po. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ATINES (View Atines Review and Atines Label ), HALCION (View Halcion Review and Halcion Label ).

6973597-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Burning Sensation, Liver Disorder, Oedema Peripheral, Pollakiuria, Rhabdomyolysis, White Blood Cell Count Decreased
on Sep 01, 2010 Male patient from JAPAN , 39 years of age, weighting 113.1 lb, was diagnosed with adjustment disorder, pollakiuria and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, burning sensation, liver disorder, oedema peripheral, pollakiuria, rhabdomyolysis, white blood cell count decreased. Remeron dosage: 15 Mg; Qd; Po. During the same period patient was treated with BUP 4 (PROPIVERINE HYDROCHLORIDE /01241602/) (20 Mg; ;po) (View Bup-4 (propiverine Hydrochloride /01241602/) Review and Bup-4 (propiverine Hydrochloride /01241602/) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DEPAS (View Depas Review and Depas Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), MAGMITT (View Magmitt Review and Magmitt Label ), GASCON (View Gascon Review and Gascon Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6971082-8 | Blood Creatine Increased, Blood Urea Increased, Communication Disorder, Delirium, Dizziness, Dysstasia, Irritability, Pancytopenia
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased, blood urea increased, communication disorder, delirium, dizziness (What is dizziness?), dysstasia, irritability, pancytopenia on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with depression (What is depression?), irritability and. Remeron dosage: See Image. During the same period patient was treated with ZYPREXA (5 Mg; Po; 10 Mg; Po) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

6959568-3 | Impulsive Behaviour, Neurosis, Overdose, Panic Attack, Skin Laceration, Suicide Attempt
Adverse event was reported on Aug 20, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg;bid;po;) was diagnosed with depression (What is depression?), panic attack, insomnia and. Location: JAPAN , 42 years of age, weighting 132.3 lb, Patient had the following side effects: impulsive behaviour, neurosis, overdose, panic attack, skin laceration, suicide attempt. During the same period patient was treated with PAXIL (10 Mg;qd;po ;po) (View Paxil Review and Paxil Label ), LORAZEPAM (1 Mg;tid;po) (View Lorazepam Review and Lorazepam Label ), SEPAZON (CLOXAZOLAM) (1 Mg;tid;po) (View Sepazon (cloxazolam) Review and Sepazon (cloxazolam) Label ), LEXOTAN (BROMAZEPAM) (2 Mg;tid;po) (View Lexotan (bromazepam) Review and Lexotan (bromazepam) Label ), HALCION (0.25 Mg; Po) (View Halcion Review and Halcion Label ), ALLELOCK (CON.) (View Allelock (con.) Review and Allelock (con.) Label ), BUSCOPAN (CON.) (View Buscopan (con.) Review and Buscopan (con.) Label ).

6959555-5 | Duodenal Ulcer Haemorrhage, Duodenal Ulcer Perforation, Gastrointestinal Haemorrhage, Haemorrhagic Anaemia, Peripheral Ischaemia, Post Procedural Complication, Shock Haemorrhagic, Weight Decreased
on Aug 12, 2010 Female patient from SWITZERLAND , 75 years of age, weighting 94.80 lb, was diagnosed with depression (What is depression?), peripheral vascular disorder, essential hypertension and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: duodenal ulcer haemorrhage, duodenal ulcer perforation, gastrointestinal haemorrhage, haemorrhagic anaemia, peripheral ischaemia, post procedural complication, shock haemorrhagic, weight decreased. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with ASPIRIN (100 Mg;qd;po) (View Aspirin Review and Aspirin Label ), ENALAPRIL MALEATE (10 Mg;qd;po) (View Enalapril Maleate Review and Enalapril Maleate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6959553-1 | Burning Sensation, Liver Disorder, Oedema Peripheral, Rhabdomyolysis, White Blood Cell Count Decreased
on Aug 18, 2010 Male patient from JAPAN , 39 years of age, weighting 113.1 lb, was diagnosed with adjustment disorder and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, liver disorder, oedema peripheral, rhabdomyolysis, white blood cell count decreased. Remeron dosage: 15 Mg;qd;po. During the same period patient was treated with BUP 4 (PROPIVERINE HYDROCHLORIDE /01293201/) (20 Mg;po) (View Bup-4 (propiverine Hydrochloride /01293201/) Review and Bup-4 (propiverine Hydrochloride /01293201/) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DEPAS (View Depas Review and Depas Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), MAGMITT (View Magmitt Review and Magmitt Label ), GASCON (View Gascon Review and Gascon Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6945958-1 | Hepatitis Acute
Patient was taking Remeron (View Usage). Patient had the following side effects: hepatitis acute on Aug 17, 2010 from GERMANY Additional patient health information: Male patient , 29 years of age, weighting 169.8 lb, . Remeron dosage: 30 Mg;qd;po; 45 Mg;qd;po. Patient was hospitalized.

6939614-3 | Rhabdomyolysis, White Blood Cell Count Decreased
Adverse event was reported on Aug 12, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 15 Mg;qd; Po) was diagnosed with adjustment disorder and. Location: JAPAN , 39 years of age, weighting 113.1 lb, After Remeron was administered, patient had the following side effects: rhabdomyolysis, white blood cell count decreased. During the same period patient was treated with BUP 4 (PROPIVERINE HYDROCHLORIDE /01241602/) (20 Mg; ;po) (View Bup-4 (propiverine Hydrochloride /01241602/) Review and Bup-4 (propiverine Hydrochloride /01241602/) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DEPAS (View Depas Review and Depas Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), MAGMITT (View Magmitt Review and Magmitt Label ), GASCON (View Gascon Review and Gascon Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6939409-0 | Disorientation, Dysarthria
on Aug 13, 2010 Female patient from ITALY , 83 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, dysarthria. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with LEVOPRAID (LEVOSULPIRIDE) (LEVOSULPIRIDE) (100 Mg;qd;po) (View Levopraid (levosulpiride) (levosulpiride) Review and Levopraid (levosulpiride) (levosulpiride) Label ). Patient was hospitalized.

6938485-9 | Disorientation, Dysarthria
on Aug 11, 2010 Female patient from ITALY , 83 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: disorientation, dysarthria. Remeron dosage: 30 Mg; Qd; Po. During the same period patient was treated with LEVOPRAID (LEVOSULPIRIDE) (LEVOSULPIRIDE) (100 Mg; Qd; Po) (View Levopraid (levosulpiride) (levosulpiride) Review and Levopraid (levosulpiride) (levosulpiride) Label ). Patient was hospitalized.

6938264-2 | Duodenal Ulcer Haemorrhage, Duodenal Ulcer Perforation, Haemorrhagic Anaemia, Peripheral Ischaemia, Post Procedural Complication, Shock Haemorrhagic, Weight Decreased
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: duodenal ulcer haemorrhage, duodenal ulcer perforation, haemorrhagic anaemia, peripheral ischaemia, post procedural complication, shock haemorrhagic, weight decreased on Aug 12, 2010 from SWITZERLAND Additional patient health information: Female patient , 75 years of age, weighting 94.80 lb, was diagnosed with depression (What is depression?), peripheral vascular disorder, essential hypertension and. Remeron dosage: 30 Mg; Qd; Po. During the same period patient was treated with ASPIRIN (100 Mg; ; Po) (View Aspirin Review and Aspirin Label ), ENALAPRIL MALEATE (10 Mg; Qd; Po) (View Enalapril Maleate Review and Enalapril Maleate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6931523-9 | Agranulocytosis
Adverse event was reported on Jul 22, 2009 by a Female patient taking Remeron (View Usage) (Dosage: Po) . Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis.

6931521-5 | Decreased Appetite, Skin Discolouration, Weight Decreased
on Sep 24, 2009 Male patient from UNITED STATES , 55 years of age, was treated with Remeron (View Usage). Patient had the following side effects: decreased appetite, skin discolouration, weight decreased. Remeron dosage: 45 Mg;qd;po.

6928336-0 | Hepatic Function Abnormal, Rhabdomyolysis
on Aug 05, 2010 Male patient from JAPAN , 39 years of age, was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: hepatic function abnormal, rhabdomyolysis. Remeron dosage: 15 Mg;qd;po.

6920184-0 | Disorientation, Dysarthria
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, dysarthria on Jul 29, 2010 from ITALY Additional patient health information: Female patient , 83 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with LEVOPRAID (LEVOSULPIRIDE) (LEVOSULPIRIDE) (100 Mg;qd;po) (View Levopraid (levosulpiride) (levosulpiride) Review and Levopraid (levosulpiride) (levosulpiride) Label ). Patient was hospitalized.

6916571-7 | Serotonin Syndrome
Adverse event was reported on Jul 27, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 15 Mg;po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 50 years of age, Patient had the following side effects: serotonin syndrome. During the same period patient was treated with ZOLOFT (150 Mg) (View Zoloft Review and Zoloft Label ), BENZODIAZEPINE (View Benzodiazepine Review and Benzodiazepine Label ), CONTMIN (View Contmin Review and Contmin Label ).

6915577-1 | Impulsive Behaviour, Laceration, Overdose, Suicide Attempt
on Jul 29, 2010 Female patient from JAPAN , 42 years of age, weighting 143.3 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: impulsive behaviour, laceration, overdose, suicide attempt. Remeron dosage: 15 Mg; Bid; Po. During the same period patient was treated with PAXIL (10 Mg; Qd; Po) (View Paxil Review and Paxil Label ), LORAZEPAM (Po) (View Lorazepam Review and Lorazepam Label ), SEPAZON (CLOXAZOLAM) (Po) (View Sepazon (cloxazolam) Review and Sepazon (cloxazolam) Label ), LEXOTAN (BROMAZEPAM) (Po) (View Lexotan (bromazepam) Review and Lexotan (bromazepam) Label ).

6906132-8 | Altered State Of Consciousness, Arrhythmia, Carditis, Therapeutic Agent Toxicity
on Jul 28, 2010 Male patient from DENMARK , 36 years of age, weighting 147.7 lb, was diagnosed with depression (What is depression?), schizophrenia and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, arrhythmia (What is arrhythmia?), carditis, therapeutic agent toxicity. Remeron dosage: 30 Mg; Po. During the same period patient was treated with ABILIFY (15 Mg; Po) (View Abilify Review and Abilify Label ), ZYPREXA (20 Mg, Po) (View Zyprexa Review and Zyprexa Label ).

6897132-5 | Hypokinesia, Serotonin Syndrome
Patient was taking Remeron (View Usage). Patient had the following side effects: hypokinesia, serotonin syndrome on Jul 20, 2010 from SWITZERLAND Additional patient health information: Male patient , 69 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 60 Mg; Qd; Po. During the same period patient was treated with EFFEXOR (75 Mg; Qd; Po) (View Effexor Review and Effexor Label ), TEMGESIC (View Temgesic Review and Temgesic Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), NORVASC (View Norvasc Review and Norvasc Label ), PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6887978-1 | C-reactive Protein Increased, Erythema, Intentional Self-injury, Nervousness, Pyrexia, Scratch, Sleep Disorder, Syncope
Adverse event was reported on Jul 17, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 30 Mg; ;po) was diagnosed with depression (What is depression?), nervousness, somnolence and. Location: SWITZERLAND , 53 years of age, After Remeron was administered, patient had the following side effects: c-reactive protein increased, erythema, intentional self-injury, nervousness, pyrexia, scratch, sleep disorder (What is sleep disorder?), syncope. During the same period patient was treated with SEROQUEL (100 Mg; ;po) (View Seroquel Review and Seroquel Label ), PACEUM (View Paceum Review and Paceum Label ). Patient was hospitalized.

6874993-7 | Completed Suicide
on Jul 18, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?), insomnia and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Remeron dosage: 15 Mg; ; Po. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6874795-1 | Accident, Off Label Use
on Jul 01, 2010 Male patient from BRAZIL , weighting 165.3 lb, was diagnosed with insomnia and was treated with Remeron (View Usage). Patient had the following side effects: accident, off label use. Remeron dosage: 30 Mg; Qd; Po. During the same period patient was treated with TYLEX /00020001/ (View Tylex /00020001/ Review and Tylex /00020001/ Label ), COCAINE (View Cocaine Review and Cocaine Label ).

6870909-8 | Amnesia
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: amnesia on Jul 14, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 15 Mg;qd;po. During the same period patient was treated with U PAN (LORAZEPAM) (0.5 Mg;tid;po) (View U Pan (lorazepam) Review and U Pan (lorazepam) Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6870899-8 | Erythema, Oedema Peripheral, Oliguria, Pleural Effusion, Rales
Adverse event was reported on Jul 13, 2010 by a Male patient taking Remeron (View Usage) (Dosage: 15 Mg;qd;po) was diagnosed with panic attack and. Location: ITALY , 64 years of age, Patient experienced the following unwanted or unexpected effects: erythema, oedema peripheral, oliguria, pleural effusion, rales. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6864935-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholestatic Liver Injury, Gamma-glutamyltransferase Increased, Q Fever, Renal Failure
on Jul 13, 2010 Female patient from SWITZERLAND , 84 years of age, weighting 163.1 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), q fever and was treated with Remeron (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestatic liver injury, gamma-glutamyltransferase increased, q fever, renal failure. Remeron dosage: 15 Mg;qd;po. During the same period patient was treated with CIPROFLOXACIN HCL (500 Mg;bid;po) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), DAFALGAN (PARACETAMOL /00020001/) (1000 Mg;po) (View Dafalgan (paracetamol /00020001/) Review and Dafalgan (paracetamol /00020001/) Label ), ZOLPIDEM TARTRATE (6.25 Mg;qd;po, 12.5 Mg;qd;po) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), DISTRANUERINE /00027501/ (View Distranuerine /00027501/ Review and Distranuerine /00027501/ Label ), CIPRALEX /01588502/ (View Cipralex /01588502/ Review and Cipralex /01588502/ Label ), TRANXILIUM (View Tranxilium Review and Tranxilium Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6864933-9 | Diarrhoea, Dizziness Postural, Dyspnoea At Rest, Erythema, Eye Swelling, Hypophagia, Nausea, Palpitations, Restlessness
on Jul 07, 2010 Female patient from SWITZERLAND , 21 years of age, weighting 101.4 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: diarrhoea, dizziness postural, dyspnoea at rest, erythema, eye swelling, hypophagia, nausea (What is nausea?), palpitations, restlessness. Remeron dosage: 15 Mg;po, 7.5 Mg;po, 15 Mg;po, 15 Mg;po. During the same period patient was treated with EFFEXOR (15 Mg;po, 75 Mg; Po, 150 Mg;po) (View Effexor Review and Effexor Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

6860938-2 | Acute Prerenal Failure, Blood Chloride Decreased, Blood Pressure Increased, Blood Sodium Increased, Dehydration, Electrocardiogram Qt Prolonged, Gastroenteritis, Off Label Use
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, blood chloride decreased, blood pressure increased, blood sodium increased, dehydration, electrocardiogram qt prolonged, gastroenteritis (What is gastroenteritis?), off label use on Jul 08, 2010 from SWITZERLAND Additional patient health information: Male patient , 68 years of age, was diagnosed with personality disorder (What is personality disorder?), psychotic disorder (What is psychotic disorder?) and. Remeron dosage: Po. During the same period patient was treated with SEROQUEL (1.5 Df; Bid; Po) (View Seroquel Review and Seroquel Label ), PRADIF (View Pradif Review and Pradif Label ), AVODART (View Avodart Review and Avodart Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6860937-0 | Completed Suicide
Adverse event was reported on Jul 12, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg; Qd; Po) was diagnosed with depressed mood, suicidal ideation and. Location: JAPAN , 42 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), RIZE (View Rize Review and Rize Label ), DEPAS (View Depas Review and Depas Label ), DEPROMEL (View Depromel Review and Depromel Label ).

6857941-5 | Abnormal Behaviour, Adjustment Disorder, Anxiety, Completed Suicide, Insomnia, Irritability, Partner Stress, Personality Disorder, Suicidal Ideation
on Jul 09, 2010 Male patient from JAPAN , 35 years of age, weighting 152.1 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: abnormal behaviour, adjustment disorder, anxiety (What is anxiety?), completed suicide, insomnia, irritability, partner stress, personality disorder (What is personality disorder?), suicidal ideation. Remeron dosage: 15mg; Po, 22.5mg;po, 30mg; Po, 45mg; Po,. During the same period patient was treated with HALCION (View Halcion Review and Halcion Label ), DEPAS (View Depas Review and Depas Label ), JZOLOFT (SERTRALINE HYDROCHLORIDE) (View Jzoloft (sertraline Hydrochloride) Review and Jzoloft (sertraline Hydrochloride) Label ), DEZOLAM (View Dezolam Review and Dezolam Label ), MINZAIN (View Minzain Review and Minzain Label ).

6847395-7 | Convulsion, Dizziness, Head Injury, Open Wound, Syncope
on Jul 06, 2010 Female patient from JAPAN , 38 years of age, weighting 123.5 lb, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, dizziness (What is dizziness?), head injury, open wound, syncope. Remeron dosage: 15 Mg;qd;po. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), SILECE (View Silece Review and Silece Label ), MYSLEE (View Myslee Review and Myslee Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), TETUCUR (View Tetucur Review and Tetucur Label ). Patient was hospitalized.

6847388-X | Altered State Of Consciousness, Disseminated Intravascular Coagulation, Hepatic Function Abnormal, Hepatitis, Pneumonia Aspiration
Patient was taking Remeron (View Usage). Patient had the following side effects: altered state of consciousness, disseminated intravascular coagulation, hepatic function abnormal, hepatitis (What is hepatitis?), pneumonia aspiration on Jul 07, 2010 from JAPAN Additional patient health information: Male patient , 94 years of age, weighting 82.67 lb, was diagnosed with depression (What is depression?), benign prostatic hyperplasia and. Remeron dosage: 15 Mg; Once;po. During the same period patient was treated with URIEF (SILODOSIN) ALPHA ADRENORECEPTOR ANTAGONISTS) (8 Mg; Once, Po) (View Urief (silodosin) Alpha-adrenoreceptor Antagonists) Review and Urief (silodosin) Alpha-adrenoreceptor Antagonists) Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), YODEL S (View Yodel S Review and Yodel S Label ), DIART (View Diart Review and Diart Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MASHI NON GAN (View Mashi-non-gan Review and Mashi-non-gan Label ), RIKKUNSHI TO (View Rikkunshi-to Review and Rikkunshi-to Label ), POSTERISAN (View Posterisan Review and Posterisan Label ). Patient was hospitalized.

6842236-6 | Condition Aggravated, Decreased Appetite, Depression, Dysuria, Hypervigilance, Insomnia, Muscle Tightness, Serotonin Syndrome
Adverse event was reported on Jul 01, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg; ; Po, 45 Mg; ; Po, 30 Mg; ; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 43 years of age, weighting 72.75 lb, After Remeron was administered, patient had the following side effects: condition aggravated, decreased appetite, depression (What is depression?), dysuria, hypervigilance, insomnia, muscle tightness, serotonin syndrome. During the same period patient was treated with U PAN (View U Pan Review and U Pan Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6842235-4 | Hepatitis Acute
on Jun 21, 2010 Female patient from GERMANY , 74 years of age, was diagnosed with depressive symptom, musculoskeletal pain and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute. Remeron dosage: ; Qd; Po. During the same period patient was treated with ARCOXIA (90 Mg; Qd; Po) (View Arcoxia Review and Arcoxia Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL /01263202/ (View Pantozol /01263202/ Review and Pantozol /01263202/ Label ), PLAVIX (View Plavix Review and Plavix Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CRESTOR (View Crestor Review and Crestor Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

6837352-9 | Diarrhoea, Fall, Headache, Loss Of Consciousness, Nausea
on Jun 30, 2010 Female patient from JAPAN , 53 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). Patient had the following side effects: diarrhoea, fall (What is fall?), headache (What is headache?), loss of consciousness, nausea (What is nausea?). Remeron dosage: 15 Mg; Qd; Po. During the same period patient was treated with DEPROMEL (View Depromel Review and Depromel Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SOLANAX (View Solanax Review and Solanax Label ), PADOPARINE (View Padoparine Review and Padoparine Label ), PROMAC (View Promac Review and Promac Label ), MAGLAX (View Maglax Review and Maglax Label ), LENDORMIN (View Lendormin Review and Lendormin Label ).

6837329-3 | Depressed Level Of Consciousness, Fatigue, Ischaemia, Somnolence
Patient was taking Remeron (View Usage). After Remeron was administered, patient had the following side effects: depressed level of consciousness, fatigue, ischaemia, somnolence on Jun 23, 2010 from GREECE Additional patient health information: Male patient , 80 years of age, . Remeron dosage: 15 Mg;. During the same period patient was treated with XANAX (1 Df;) (View Xanax Review and Xanax Label ).

6837297-4 | Affect Lability, Burning Sensation, Nasopharyngitis, Serotonin Syndrome
Adverse event was reported on Jun 28, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg; Qd; Po, 30 Mg; Qd; Po) was diagnosed with depression (What is depression?), affect lability and. Location: JAPAN , 61 years of age, weighting 93.04 lb, Patient experienced the following unwanted or unexpected effects: affect lability, burning sensation, nasopharyngitis, serotonin syndrome. During the same period patient was treated with ZYPREXA (5 Mg; ; Po) (View Zyprexa Review and Zyprexa Label ), VALERIN (View Valerin Review and Valerin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

6818998-0 | Inappropriate Antidiuretic Hormone Secretion
on Jun 28, 2010 Female patient from JAPAN , 79 years of age, was treated with Remeron (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion. Remeron dosage: ; Po. During the same period patient was treated with TOLEDOMIN (View Toledomin Review and Toledomin Label ).

6815453-9 | Angle Closure Glaucoma
on Jun 22, 2010 Female patient from GREECE , 50 years of age, was diagnosed with depression (What is depression?) and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: angle closure glaucoma. Remeron dosage: 15 Mg; Qd;.

6811935-4 | Completed Suicide
Patient was taking Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jun 22, 2010 from JAPAN Additional patient health information: Male patient , 35 years of age, was diagnosed with depression (What is depression?) and. Remeron dosage: 15 Mg; ; Po, 30 Mg; ; Po, 45 Mg; ; Po. During the same period patient was treated with HALCION (View Halcion Review and Halcion Label ), DEPAS (View Depas Review and Depas Label ).

6800895-8 | Dizziness, Fall, Head Injury, Syncope
Adverse event was reported on Jun 17, 2010 by a Female patient taking Remeron (View Usage) (Dosage: 15 Mg;qd;po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 38 years of age, Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), head injury, syncope. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), SILECE (View Silece Review and Silece Label ), MYSLEE (View Myslee Review and Myslee Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

6799954-8 | Decreased Appetite, Dysuria, Hypervigilance, Insomnia, Muscle Tightness, Serotonin Syndrome
on Jun 10, 2010 Female patient from JAPAN , 43 years of age, weighting 72.75 lb, was diagnosed with depression (What is depression?), insomnia and was treated with Remeron (View Usage). After Remeron was administered, patient had the following side effects: decreased appetite, dysuria, hypervigilance, insomnia, muscle tightness, serotonin syndrome. Remeron dosage: 15 Mg;po 45 Mg;po 30 Mg;po. During the same period patient was treated with SEROQUEL (Po) (View Seroquel Review and Seroquel Label ), U PAN (View U Pan Review and U Pan Label ). Patient was hospitalized.

6799952-4 | Coma Scale Abnormal, Serotonin Syndrome
on Jun 09, 2010 Male patient from SWITZERLAND , 30 years of age, was diagnosed with sleep disorder (What is sleep disorder?), depression (What is depression?) and was treated with Remeron (View Usage). Patient experienced the following unwanted or unexpected effects: coma scale abnormal, serotonin syndrome. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with ESCITALOPRAM OXALATE (20 Mg;qd;po) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), ZYPREXA (10 Mg;qd;po) (View Zyprexa Review and Zyprexa Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6799479-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Muscle Strain
Patient was taking Remeron (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, muscle strain on Jun 15, 2010 from GERMANY Additional patient health information: Male patient , 48 years of age, weighting 205.0 lb, was diagnosed with major depression and. Remeron dosage: 30 Mg;qd;po. During the same period patient was treated with TREVILOR RETARD (View Trevilor Retard Review and Trevilor Retard Label ), PANTOZOL (View Pantozol Review and Pantozol Label ).